Skip to Main Content

Paper Details

The clinical impact of the molecular landscape of acute myeloid leukemia.
Haematologica
22
2023
AML, FLT3, IDH, acute myeloid leukemia, enasidenib, gemtuzumab, gemtuzumab ozogamicin, gilteritinib, ivosidenib, leukemia, magrolimab, menin, midostaurin, myeloid neoplasms, quizartinib, tumor, tumor genome, venetoclax
Author NameAffiliation
Mark J LevisSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University Baltimore
Mark J LevisSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University Baltimore
  • 1 - 2

Datasets

Release 1.2